GlassScriptPhysician profile
Rohan Trivedi
NPI 1972953586
$35,990.68
in general payments reported to CMS, 2019-2025
18 companies · $5,294 in 2025
The $5,294 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $18.85 · 2021: $130 · 2022: $5,477 · 2023: $17K · 2024: $7,682 · 2025: $5,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $11K · Travel and Lodging: $9,873 · Food and Beverage: $7,095 · Consulting Fee: $2,000 · Education: $493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,791.34 |
| Travel and Lodging | $9,872.64 |
| Food and Beverage | $7,094.94 |
| Consulting Fee | $2,000.00 |
| Education | $492.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $23,285.89 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Selectsecure |
| Abbott Laboratories | $5,898.74 | 2022-2025 | Ensite Precision, Ensite, Aveir |
| Biotronik INC. | $5,743.96 | 2022-2025 | Solia, Edora 8 Dr-T, Sentus |
| Boston Scientific Corporation | $392.59 | 2022-2025 | Farapulse, Watchman Flx |
| Novartis Pharmaceuticals Corporation | $148.25 | 2025 | |
| Pfizer INC. | $141.34 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $79.55 | 2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $36.22 | 2025 | Eliquis |
| Bridgebio Pharma, INC. | $34.98 | 2025 | Attruby |
| Scpharmaceuticals INC. | $33.47 | 2025 | |
| Alnylam Pharmaceuticals INC. | $30.26 | 2025 | Amvuttra |
| Abiomed | $29.92 | 2025 | |
| Merck Sharp & Dohme LLC | $29.84 | 2025 | Verquvo |
| Novo Nordisk INC | $24.31 | 2025 | Wegovy |
| Amgen INC. | $23.81 | 2025 | Repatha |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cleerly, INC. | $20.94 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Sanofi-Aventis U.S. LLC | $18.85 | 2020 | |
| Heartflow, INC. | $17.76 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohan Trivedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.